Quarterly ResultMay 6, 2026, 04:19 PM
agilon health Q1 Net Income $48.9M; EPS $2.94; Reverse Stock Split
AI Summary
agilon health reported a significant increase in net income and diluted EPS for the first quarter of 2026, reaching $48.9 million and $2.94, respectively, despite a decrease in total revenues to $1.42 billion. The company also saw a positive swing in net cash provided by operating activities to $23.7 million. A 1-for-25 reverse stock split was completed on March 30, 2026, and the company amended its credit facility, extending the maturity of its Secured Term Loan Facility.
Key Highlights
- Net income attributable to common shares rose to $48.9M in Q1 2026 from $12.1M in Q1 2025.
- Diluted earnings per common share increased to $2.94 in Q1 2026 from $0.73 in Q1 2025.
- Total revenues decreased to $1.42B in Q1 2026 from $1.53B in Q1 2025.
- Medical services expense decreased to $1.27B in Q1 2026 from $1.40B in Q1 2025.
- Net cash provided by operating activities was $23.7M in Q1 2026, up from $(32.0M) in Q1 2025.
- Total assets increased to $1.50B as of March 31, 2026, from $1.27B as of December 31, 2025.
- A 1-for-25 reverse stock split was effected on March 30, 2026.
- The Secured Term Loan Facility had $31.5M outstanding as of March 31, 2026.